- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-1-1-3-mer
- Ligands
- 3 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 18 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.4: 6 residues within 4Å:- Chain C: S.114, E.134, N.163, N.164
- Chain E: Y.352, T.471
Ligand excluded by PLIPNAG.5: 3 residues within 4Å:- Chain C: Y.32, N.65, P.632
Ligand excluded by PLIPNAG.6: 3 residues within 4Å:- Chain C: N.332, Q.581, T.582
Ligand excluded by PLIPNAG.7: 4 residues within 4Å:- Chain C: N.281, E.282, N.283
- Chain E: K.559
Ligand excluded by PLIPNAG.8: 6 residues within 4Å:- Chain C: N.718, F.719, T.720, L.923, Q.927, Q.1072
Ligand excluded by PLIPNAG.9: 3 residues within 4Å:- Chain C: N.802, S.804, Q.805
Ligand excluded by PLIPNAG.10: 4 residues within 4Å:- Chain C: N.710, N.711
- Chain D: I.795, Y.797
Ligand excluded by PLIPNAG.11: 4 residues within 4Å:- Chain C: E.1073, N.1075
- Chain D: A.894, Q.896
Ligand excluded by PLIPNAG.12: 4 residues within 4Å:- Chain C: N.1099, T.1101, H.1102, F.1104
Ligand excluded by PLIPNAG.13: 2 residues within 4Å:- Chain D: N.802, S.804
Ligand excluded by PLIPNAG.14: 2 residues within 4Å:- Chain D: N.718, L.923
Ligand excluded by PLIPNAG.15: 1 residues within 4Å:- Chain D: N.710
Ligand excluded by PLIPNAG.16: 3 residues within 4Å:- Chain D: N.1099, H.1102, F.1104
Ligand excluded by PLIPNAG.17: 1 residues within 4Å:- Chain D: N.1135
Ligand excluded by PLIPNAG.18: 2 residues within 4Å:- Chain C: Y.797
- Chain E: N.710
Ligand excluded by PLIPNAG.19: 3 residues within 4Å:- Chain E: N.718, L.923, Q.927
Ligand excluded by PLIPNAG.20: 4 residues within 4Å:- Chain E: F.343, N.344, V.368, N.371
Ligand excluded by PLIPNAG.21: 2 residues within 4Å:- Chain E: N.617, Q.645
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Hastie, K.M. et al., Potent Omicron-neutralizing antibodies isolated from a patient vaccinated 6 months before Omicron emergence. Cell Rep (2023)
- Release Date
- 2023-05-03
- Peptides
- Antibody 1C3 Fab Heavy Chain: A
Antibody 1C3 Fab Light Chain: B
Spike glycoprotein: CDE - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
XB
YC
AD
BE
C
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-1-1-3-mer
- Ligands
- 3 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 18 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Hastie, K.M. et al., Potent Omicron-neutralizing antibodies isolated from a patient vaccinated 6 months before Omicron emergence. Cell Rep (2023)
- Release Date
- 2023-05-03
- Peptides
- Antibody 1C3 Fab Heavy Chain: A
Antibody 1C3 Fab Light Chain: B
Spike glycoprotein: CDE - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
XB
YC
AD
BE
C